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This study aimed to identify burden and risk of VTE associated with cholecystectomy in 
England.  
Methods:  
An historical cohort study of cholecystectomy patients from 2001-2011 was undertaken 
using linked primary (Clinical Practice Research Datalink) and secondary (Hospital Episode 
Statistics) care data. Crude rates and adjusted hazard ratios (HRs) were calculated for risk 
of VTE following cholecystectomy using Cox regression. 
Results:   
24 677 patients were identified with a rate of VTE in the first year following cholecystectomy 
of 2.80 per 1000 person years (95% CI 2.18-3.59). Patients aged >/=70 vs aged <50 had 
8.3-fold increase in risk of VTE (HR 8.27, 95% CI 3.72-18.35); patients with BMI >30 vs BMI 
<30 had 2.4-fold increase in risk (HR 2.42, 95% CI 1.40-4.18); open vs laparoscopic 
operation had 3-fold increase in risk (HR 2.94, 95% CI 1.55-5.55).  Compared to general 
population, VTE risk was highest in the first 30 days post-operatively with 9.9-fold risk 
following emergency cholecystectomy and 4.5-fold risk after inpatient cholecystectomy (HR 
9.90, 95% CI 4.42-22.21; HR 4.54, 95% CI 2.85-7.21). 
Conclusions:  
Cholecystectomy is associated with a low absolute risk of VTE we have identified high risk 




Over 66 000 cholecystectomies are performed each year in England at a cost of around 
£111.6 million[1]. The majority of these are performed laparoscopically, allowing early 
ambulation and reduced length of hospital stay which should decrease the risk of VTE [2]. 
However it has been proposed that the laparoscopic approach could paradoxically increase 
the risk of VTE due to pneumoperitoneum induction, activation of the coagulation system 
and the historically longer duration of procedure [3]. Current studies reporting the risk of VTE 
associated with cholecystectomy are not population based and much of the data from these 
studies are no longer contemporary [4-10]. These studies focus on the inpatient period only 
or follow up to 30 days only, relying on either secondary care data or surveillance methods 
and therefore may not reflect true rates of clinically important VTE [3, 11]. 
Little is known regarding the timescale of VTE risk following cholecystectomy and no studies 
have stratified their follow-up period to address this. Additionally, it has not been established 
if variation in the risk of VTE occurs between emergency (surgery during same admission 
as emergency presentation), elective (admission on elective basis for surgery) or day-case 
admissions (admission and discharge on same day as surgery). A prior population based 
study reported 90 day rates of VTE using linked primary and secondary data however no 
description of risk by individual procedure type was reported[12]. Persson et al investigated 
bleeding and VTE risk following cholecystectomy using the Swedish Register of Gallstone 
Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks) to identify 
cholecystectomies from 2005 to 2010. They reported that VTE prophylaxis was associated 
with increased bleeding risk but with no reduction in VTE risk[13]. However the population 
studied may not be generalisable to practice in other countries as they did not report whether 
elective procedures were day case or inpatient, and no association with obesity was 
reported. In that particular study, pharmacological VTE prophylaxis was prescribed based 
on the individual surgeons’ risk assessment, rather than defined risk criteria. Identifying 
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those patients at high risk of VTE and the time period at risk would allow targeted 
thromboprophylaxis to minimise the risk of VTE whilst preventing an excess risk of bleeding 
events [14]. 
This study aimed to identify the burden, timing and risk factors for VTE associated with 
cholecystectomy in England using population-based, linked primary and secondary care 
data from England. This study also aimed to identify specific sub-groups with increased risk 
of VTE to target for consideration of prophylaxis. 
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MATERIAL AND METHODS 
Patients and data sources 
This study used data from two linked health care databases which we have described in 
detail previously [15, 16]. In brief the Clinical Practice Research Datalink (CPRD) contains 
diagnostic and prescription data coded using Read codes[17] for approximately 3.4 million 
active patients. CPRD has been linked to Hospital Episodes Statistics data (HES) which 
contains a detailed record for each 'episode' of admitted patient care delivered in England, 
either by NHS hospitals or delivered in the independent sector but commissioned by the 
NHS. Records are coded using a combination of International Statistical Classification of 
Disease and Related Health Problems (ICD-10) for primary diagnosis at discharge along 
with Office of Population, Censuses and Surveys Classification of Surgical Operations and 
Procedures version 4 (OPCS 4) detailing procedures performed. The anonymised patient 
identifiers from CPRD and HES were linked by a trusted (anonymous) third party by using 
the National Health Service (NHS) number, date of birth, postcode, and sex. Most patients 
were matched exactly according to NHS number (over 90% of patients are linked in this 
way), with the remaining patients linked probabilistically on the basis of postcode, date of 
birth, and sex. We also used death certificate data from the Office for National Statistics 
(ONS).   
Cohort Identification 
The cohort was identified from CPRD-HES linked data using OPCS codes for 
cholecystectomy (Codes J181, J182, J183, J184, J185, J188, J189). A laparoscopic 
approach was confirmed by the inclusion of an OPCS code for laparoscopy Y508, Y571 and 
Y752. Follow up was until development of a VTE event, death, leaving a participating GP 
practice or 31st Dec 2011, whichever was earliest. Those under the age of 18 years were 
excluded as we have reported the data previously [18].  
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The population cohort was identified from the CPRD-HES linked data. In order to maximize 
statistical power, all available controls without a diagnosis of surgery during their CPRD-
HES record were eligible. The population cohort were drawn from a larger study of all 
patients undergoing gastrointestinal surgery in which they were frequency matched in a ratio 
of 10:1 by 5-year-age bands to those undergoing surgery. They received a pseudo-
diagnosis date generated at random between the study start and end date (2001-2011).  
Outcome Definition 
VTE diagnosis was determined from medical codes in the CPRD and HES (using Read and 
ICD-10 respectively). These were considered to be a VTE event if supported by either: a 
prescription for an anticoagulant or other evidence of treatment in an anticoagulation clinic 
(such as a medical code) between 15 days before and 90 days after the VTE diagnosis, or 
a date of death within 30 days of the event. Additionally, an underlying cause of death of 
VTE was included as evidence of VTE diagnosis. Only the first confirmed instance of VTE 
was included in the analysis. We took the date of diagnosis of VTEs to be the episode start 
date for VTEs occurring within the same hospital spell as the index operation. Participants 
were excluded if they had a VTE prior to admission for cholecystectomy. The definition using 
primary care data alone has been validated previously showing 84% of cases were valid[19] 
and used in our prior studies of VTE[20, 21]. 
Exposures 
Comorbidity was determined from the CPRD and HES data and classified using the 
Charlson index prior to admission for surgery and categorised as no comorbidity, 1 
comorbidity or 2 or more comorbidities[22]. Body mass index (BMI) was defined from the 
primary care data and classified as less than 30 kg/m2, greater than or equal to 30 kg/m2 or 
missing. Finally, admission type was defined as in-patient, emergency or day case based 
on the type of admission recorded for the surgical procedure. 
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Statistical Analysis 
First, we described the basic characteristics of our cohort using frequencies and 
percentages. Median ages were calculated and compared using Kruskal Wallis Test. 
Absolute rates of VTE (per 1000 person years) were calculated for the first year following 
surgery. These rates were then stratified by age, comorbidity, BMI and admission type. The 
impact of these factors on VTE risk was assessed in terms of Hazard ratios (HR) using a 
Cox regression model compared to the baseline group for each category. The post 
discharge period was further stratified into individual months up to 3 months. Cox regression 
analysis was again used to provide HRs for each time interval at risk comparing risk of those 
undergoing in-patient, emergency or day case cholecystectomy compared to the general 
population. Missing data was fitted as a separate category in all analyses. All data 
management and analysis were performed using Stata 14 (Statacorp, Texas 77845 USA). 
The study had approval from the Independent Scientific Advisory Committee approval board 
which provides scientific advice to the Medicines and Healthcare products Regulatory 
Agency (MHRA) (Protocol 11-051R). 
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RESULTS 
Demographics of cohort 
We identified 24 677 people undergoing a cholecystectomy with the majority having their 
operation as an inpatient electively (76.9%; 18 975/24 677) (Table 1). Of those having a 
cholecystectomy, 76.9% (18 975/24 677) were female. The median age at operation was 
53 years (inter quartile range (iqr) 40-65 years) compared to 52 years (iqr 38-65) in the 
population cohort. Those undergoing in-patient and emergency cholecystectomy had higher 
levels of comorbidity than those undergoing day case surgery (Table 1). The median length 
of stay following an inpatient procedure was 1 day (iqr 1-3 days) compared with a median 
of 7 days (iqr 4-11 days) for an emergency procedure. Laparoscopic cholecystectomy was 
undertaken in 97.6% (3156/3234) of day case procedures, 89.1% (16 910/18 975) of 
inpatient elective procedures and 73.6% (1817/2468) of emergency procedures. In total 
84.4% (20 829/24 677) of procedures were undertaken for cholelithiasis and 13.6% 
(3354/24 677) for acute cholecystitis. 
Absolute rates of VTE following cholecystectomy 
The overall rate of VTE in the first year following cholecystectomy was 2.80 per 1000 person 
years (95% CI 2.18-3.59) (Table 2). The rates of VTE increased with increasing age, peaking 
in patients aged 70 and over (absolute rate of 8.00 per 1000 person years (95% CI 5.52-
11.58)). This represented an adjusted 8.3-fold increase in overall VTE risk compared to 
patients aged under 50 years (HR 8.27, 95% CI 3.72-18.35) (Table 2) and there was 
evidence that this increase was linear across the age groups (p<0.001). 
Absolute rates of VTE were higher in patients with obesity compared to patients without 
obesity (3.81 per 1000 person years (95% CI 2.68-5.42) vs 2.00 per 1000 person years 
(95% CI 1.33-3.01). This increase represented an adjusted 2.4-fold risk of developing VTE 
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post-operatively compared to patients with a BMI under 30 (HR 2.42, 95% CI 1.40-4.18) 
(Table 2). 
The absolute rate of VTE was lower in laparoscopic procedures compared to open 
procedures (2.19 per 1000 person years (95% CI 1.62-2.95) vs 9.25 per 1000 person years 
(95% CI 5.47-15.61)). This represented an adjusted 3-fold increased risk of VTE for open 
procedures compared to laparoscopic (HR 2.94, 95% CI 1.55-5.55) (Table 2). 
The absolute rate of VTE following day case surgery was low (1.47 per 1000 person years). 
There was no-significant increase in risk of VTE following emergency or in-patient surgery 
when accounting for other factors. 
Relative risk of VTE following cholecystectomy by mode of surgery compared to the general 
population 
When compared to the general population, absolute rates of VTE following cholecystectomy 
were highest in the first month following surgery. Those having an emergency 
cholecystectomy had the highest absolute rate (31.65 per 1000 person years (95% CI 14.22 
– 70.45) vs 3.16 per 1000 person years in the general population (95% CI 2.87 – 3.49)). 
This represented an adjusted 9.9-fold VTE risk following emergency cholecystectomy (HR 
9.90, 95% CI 4.42-22.21) compared to the general population (Table 3). Those having 
inpatient procedures also had higher absolute rates of VTE than in the general population 
(absolute rate 12.87 per 1000 person years (95% CI 8.21-20.18) vs 3.16 per 1000 person 
years (95% CI 2.87 – 3.49)). This represented an adjusted 4.5-fold risk of developing VTE 
(HR 4.54, 95% CI 2.85-7.21). No VTE events were recorded in day-case patients in the first 





Summary of findings 
Absolute rates of VTE following cholecystectomy are low. However, we found increasing 
age, obesity and open operations all carried an increased relative risk of VTE. The risk of 
VTE was highest in the first month after surgery, particularly following emergency admission, 
with a 9.9-fold VTE risk following emergency cholecystectomy in the first month post-
operatively compared to the general population. The absolute rates returned towards the 
population level in the second month following surgery.  
Limitations and strengths of study 
This study used linked healthcare data to identify patients undergoing cholecystectomy from 
population-based data, with identification of operative procedures from secondary care 
along with the definition of VTE in a validated manner from primary and secondary care, 
therefore it is uniquely placed to quantify VTE risk reasonably accurately[19]. The 
identification of VTE in these patients relies on the clinical suspicion of their practitioner and 
subsequent referral for investigation, thus minimising surveillance bias that may occur in 
patients identified solely in hospital, as has been suggested in other studies[11]. Using linked 
prescription data allowed a validated measure of clinically significant VTE events, giving a 
good representation of clinical VTE burden. This study detected symptomatic VTE only 
rather than using surveillance measures that would identify clinically silent events. As such 
the true rates of VTE may be higher than reported in the present study findings. An important 
limitation of this study is that the data available did not contain detail about pharmacological 
or mechanical prophylaxis that was prescribed in hospital.  No data on prescription or use 
of mechanical prophylaxis was available in the present study, therefore we are unable to 
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comment on its importance. However, previous reports have suggested that many patients 
at risk of VTE are not prescribed any pharmacological prophylaxis while in hospital [23, 24]. 
The present study contains data from 2001 to 2011. It should be noted that the current 
guidance was published in 2010, and as such the data from before this period may not 
reflect current best practice [2, 25]. Nevertheless, current guidance does not define patients 
groups with higher risk, nor does it offer guidance on the timing of risk. The present study 
aimed to clarify these aspects of VTE risk in relation to cholecystectomy. 
Other literature 
Previous work by Sinha et al identified characteristics of patients undergoing 
cholecystectomy using HES data [26]. The population identified in the present study showed 
similarities with regard to gender (76.9% female vs 76.1%female), age (median age 53 vs 
mean age 52), proportion undergoing emergency procedures (10.0% (2468/24677) vs 
12.5%) and proportion converted from laparoscopic to open (4.5% (1104/24677) vs 5.0%). 
However, our population had more co-morbidities recorded with 16.8% (4154/24 677) of 
patients with a Charlson score of 2 or more (compared to 2.5%) and 60.7% (14 967/24 677) 
of patients with a Charlson score of 0 (compared to 83.1%). This difference is likely due to 
improved recording in the current study, given the availability of primary care data and the 
completeness of comorbidity recording, compared to the reliance on secondary care data in 
the Sinha study[19].  
Bouras et al also analysed linked primary and secondary care data for 90 days following 
general surgical procedures and reported symptomatic VTE in 0.3% of patients overall after 
cholecystectomy, which is in line with our estimate (0.25%)[12]. However they did not report 
on the associated risk factors or timing of events for cholecystectomy, limiting their results 
in application to clinical decision-making. Stromberg et al described symptomatic VTE in 
0.25% of post-cholecystectomy patients overall. They also found increased risk in over 70s 
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and with open cholecystectomy. These findings are supported by the present study. 
However the data used were from the Swedish Register of Gallstone Surgery and 
Endoscopic Retrograde Cholangiopancreatography, were followed for only 30 days and it is 
not stated whether elective procedures were performed as inpatient or day case [7]. 
Age has previously been shown to be associated with increased risk of VTE following 
cholecystectomy. In this study an 8.3-fold increase in overall VTE risk was seen in patients 
aged over 70 years compared to patients aged under 50 years. Using measurement of 
coagulation factors pre- and post- laparoscopic cholecystectomy, it has been suggested by 
Garg et al that age may be an important risk factor for activation of coagulation, theoretically 
increasing the risk of VTE, although no actual VTE events were recorded in their study [27]. 
Indeed, Stein et al reported the prevalence of VTE after laparoscopic cholecystectomy 
increased from 0.17% in patients aged 21 to 30 years to 0.90% in patients aged 71 to 80 
years, similar to our findings[28]. White et al reported a steady increase in the incidence of 
VTE with increasing age in cholecystectomy[8]. Both of these studies used data from the 
USA and used only secondary care rather than prescription-validated data.  
Obesity has also been suggested as a risk factor for hypercoagulability, and therefore a 
subsequent VTE risk, following cholecystectomy [27]. In the present study, obesity was 
found to be associated with increased risk of VTE with a 2.4-fold increased risk of VTE 
compared to patients with a BMI under 30 kg/m2. Other studies have also reported increased 
incidence of DVT or PE following open cholecystectomy, as supported by the present data, 
which demonstrate higher VTE risk after open cholecystectomy compared to 
laparoscopic[5-7, 10, 29]. This may be due to early ambulation and shorter inpatient period 
stay facilitated by undergoing laparoscopic compared to open cholecystectomy [2]. 
In the present study, we have identified the first 30 days as the highest risk period. There is 
little information available regarding timing of symptomatic VTE events following 
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cholecystectomy in other literature. Many studies used surveillance methods to detect VTE 
within days to weeks of cholecystectomy although this included clinically silent VTE [4, 5, 
30]. Other studies using routinely collected data followed patients for 30 days only and used 
only secondary care data[7, 13]. Three studies reported overall VTE rate at 90 and 91 days 
but failed to further identify variation in risk over this time period[8, 10, 12].  
Clinical Significance  
While cholecystectomy in general is a low risk procedure for VTE, this study has identified 
certain groups of patients who have increased risk of developing VTE. This includes patients 
who are obese, elderly or who undergo open procedures. These groups of patients should 
therefore be considered for pharmacological VTE prophylaxis as VTE risk may outweigh the 
bleeding risk. However the majority of patients following cholecystectomy are at low risk of 
VTE and therefore do not warrant routine extended thromboprophylaxis beyond the inpatient 
period. More work is needed to identify the bleeding risk associated with pharmacological 
thromboprophylaxis in these higher risk groups to guide decision making for inpatient or 
extended pharmacological thromboprophylaxis. Using data from the present study, no 
conclusions regarding use of mechanical thromoboprophylaxis can be made therefore the 
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Table 1. Demographics of those undergoing cholecystectomy by method of admission and 
population controls.  
  General Population Day case Elective Emergency 
  No. % No. % No. % No. % 
Gender 
      
Male 787,484 47.1 634 19.6 4,373 23 695 28.2 
Female 884,065 52.9 2,600 80.4 14,602 77 1,773 71.8 
Age 
        
>/=18-49 711,922 42.6 1746 54.0 7544 39.8 1081 43.8 
50-59 287,821 17.2 730 22.6 4,222 22.3 432 17.5 
60-69 299,473 17.9 572 17.7 3,943 20.8 405 16.4 
>/=70 372,333 22.3 186 5.8 3,266 17.2 550 22.3 
Comorbidity 
        
0 1,080,906 64.7 2,204 68.2 11,440 60.3 1,323 53.6 
1 292,780 17.5 690 21.3 4,248 22.4 618 25 
>/=2 297,863 17.8 340 10.5 3,287 17.3 527 21.4 
BMI (kg/m2) 
        
<30 1,000,395 59.8 1,728 53.4 9,787 51.6 1,214 49.2 
>/=30 286,511 17.1 1,183 36.6 7,061 37.2 956 38.7 
Missing 384,643 23 323 10 2,127 11.2 298 12.1 
Laparoscopic 




3,156 97.6 16,910 89.1 1,817 73.6 
No 
  
77 2.4 1,176 6.2 437 17.7 
Converted 
  






Table 2. Rates of VTE in patients undergoing cholecystectomy.* corrected for all other 
variables in table and admission type. 
 
  Absolute Rates Univariate Cox Model Multivariate Cox Model* 
    Events Time Rate  95% CI HR 95% CI HR 95% CI 
Gender Male 17 5.01 3.36 2.09-5.41 ref   ref 
 
  Female 45 17.08 2.63 1.97-3.53 0.78 0.45-1.37 1.16 0.65-2.07 
Age (years) >/=18-49 9 9.29 0.96 0.50-1.86 ref   ref 
 
 
50-59 9 4.9 1.84 0.96-3.53 1.89 0.75-4.77 1.95 0.77-4.92 
 
60-69 16 4.45 3.60 2.20-5.87 3.70 1.64-8.38 3.78 1.64-8.70 
  >/=70 28 3.5 8.00 5.52-11.58  8.17 3.85-17.31 8.27 3.72-18.35 
BMI <30 23 11.5 2.00 1.33-3.01 ref   ref 
 
 
≥30 31 8.13 3.81 2.68-5.42 1.90 1.11-3.27 2.42 1.40-4.18 
  Missing 8 2.51 3.18 1.60-6.38 1.59 0.71-3.56 1.93 0.86-4.34 
Comorbidity 0 30 13.58 2.21 1.55-3.16 Ref   ref 
 
 
1 15 4.94 3.04 1.83-5.04 1.37 0.74-2.55 1.06 0.57-1.98 
  ≥2 17 3.62 4.70 2.92-7.56 2.12 1.17-3.85 1.07 0.57-2.01 
Laparoscopic Laparoscopic 43 19.63 2.19 1.62-2.95 Ref   ref 
 
 
Open  14 1.51 9.25 5.47-15.61 4.20 2.30-7.67 2.94 1.55-5.55 






*adjusted for gender, age, comorbidity, BMI  
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Table 3.  Rates of VTE by mode of admission over follow-up period. 
     Univariate Multivariate* 
  
Rates of VTE  
(per 1000 person years) 
95% CI 
HR 95% CI HR 95% CI 




General population 3.16  2.87-3.49 ref   ref 
 
Day Case 0  0   0 
 
In-patient 12.87  8.21-20.18 4.07 2.57-6.44 4.54 2.85-7.21 
Emergency 31.65  14.22-70.45 10.00 4.47-22.40 9.90 4.42-22.21 
2nd Month            
General population 3.04  2.75-3.35 ref   ref 
 
Day Case 0  0   0 
 
In-patient 4.64 2.21-9.74 1.53 0.72-3.23 1.66 0.79-3.52 
Emergency 5.24  0.74-37.19 1.73 0.24-12.28 1.66 0.23-11.84 
3rd Month            
General population 2.71  2.43-3.02 ref   ref 
 
Day Case 4.04 0.57-28.67 1.49 0.21-10.61 2.43 0.34-17.33 
In-patient 0  0   0 
 







*adjusted for gender, age, comorbidity, BMI 
 
